Bio-Thera Conducts Simponi Phase III Trial

Study In Psoriatic Arthritis Patients Begins For BAT2506 Golimumab Biosimilar

 
• By David Wallace
Clinical_Trial_Puzzle
Bio-Thera has kicked off a Phase III study for its golimumab biosimilar • Source: Shutterstock

More from Biosimilars

More from Products